Can eradication therapy for Helicobacter pylori really improve the thrombocytopenia in idiopathic thrombocytopenic purpura? Our experience and a literature review

International Journal of Hematology

Volumn 77, Issue 3, 2003, Pages 239-244

  Ando, Keiko ^a   Shimamoto, Takashi ^a   Tauchi, Tetsuzo ^a   Ito, Yoshikazu ^a   Kuriyama, Yuzuru ^a   Gotoh, Akihiko ^a   Miyazawa, Keisuke ^a   Kimura, Yukihiko ^a   Kawai, Takashi ^a   Ohyashiki, Kazuma ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Eradication therapy; Helicobacter pylori; Idiopathic thrombocytopenic purpura

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; PREDNISONE;

ADULT; AGED; AUTOIMMUNE DISEASE; ERADICATION THERAPY; FEMALE; FOLLOW UP; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PATHOGENESIS; PREVALENCE; REVIEW; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

EID: 0141569452     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983780     Document Type: Review

References (26)

1. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med. 1992;116:705-708.
2. Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ. 1991;302:1302-1305.
3. Zentilin P, Savarino V, Garnero A, Accardo S, Seriolo B. Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis? Gastroenterology. 1999;116:503-504.
4. De Luis DA, Varela C, de la Calle H, et al. Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol. 1998;26:259-263.
5. Gasbarrini A, Franceschi F. Autoimmune diseases and Helicobacter pylori infection. Biomed Pharmacother. 1999;53:223-226.
6. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet. 1998;352:878.
7. Negrini R, Savio A, Poiesi C, et al. Antigen mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology. 1996;111:655-665.
8. McCrae KM, Bussel JB, Mannucci PI, Remuzzi G, Cines DB. Platelets: an update on diagnosis and management of thrombocytopenic disorders. Hematology (Am Soc Hematol Educ Prog). 2001:282-305.
9. Francois B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H. Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med. 1997;103:114-120.
10. Nagamine T, Ohtuka T, Takehara K, Takagi H, Mori M. Thrombocytopenia associated with hepatitis C viral infection. J Hepatol. 1996;24:135-140.
11. Hohmann AW, Booth K, Peter V, Gordon DL, Comacchio RM. Common epitope on HIV p24 and human platelets. Lancet. 1993;342:1274-1275.
12. Grimaz S, Damiani D, Brosolo P, Skert C, Geromin A, de Pretis G. Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report. Haematologica. 1999;84:283-284.
13. Emilia G, Longo G, Luppi M, et al. Helicobacter pylori eradication can induce platelet recovery in idiopathic thrombocytopenic purpura. Blood. 2001;97:812-814.
14. Kohda K, Kuga T, Kogawa K, et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura. Br J Haematol. 2002;118:584-588.
15. Jarque I, Andreu R, Llopis I, et al. Absence of platelet response after eradication of Helicobacter pylori infection in patients with chronic idiopathic thrombocytopenic purpura. Br J Haematol. 2001;115:1002-1003.
16. Asaka M, Kimura T, Kudo M, et al. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 1992;102:760-766.
17. Fukuda Y, Tomita Y, Sakagami T, Shimoyama T. Epidemiology of H pylori infection [in Japanese]. Nippon Rinsho. 2002;60(suppl 2):40-48.
18. McMillan R. Therapy for adults refractory chronic immune thrombocytopenic purpura. Ann Int Med. 1997;126:307-314.
19. Kawai T, Kawakami K, Kudo S, et al. A new serum antibody test kit for evaluation of Helicobacter pylori eradication. Int Med. 2002;41:780-783.
20. Cheson BD, Bennett JM, Kantarjian H, et al. Report of an international working group to standardize response criteria for myelodysplastic syndromes. Blood. 2000;96:3671-3674.
21. Cabtree JE, Lindley IJ. Mucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease. Eur J Gastroenterol Hepatol. 1994;6(suppl 1):S33-S38.
22. Shimoyama T, Crabtree JE. Bacterial factors and immune pathogenesis in Helicobacter pylori infection. Gut. 1998;43(suppl 1):S2-S5.
23. Akiyama H, Onozawa Y. Effect of omeprazole in chronic idiopathic thrombocytopenic purpura. Am J Hematol. 1998;57:91-92.
24. Luzza F, Imeneo M, Maletta M, et al. Suggestion against an oral-oral rout of transmission for Helicobacter pylori infection: a seroepidemiological study in a rural area. Dig Dis Sci. 1998;43:1488-1492.
25. Tovey FI, Hobsley M. Is Helicobacter pylori the primary cause of duodenal ulceration? J Gastroenterol Hepatol. 1999;14:1053-1056.
26. George JN. Initial management of adults with idiopathic (immune) thrombocytopenic purpura. Blood Rev. 2002;16:37-38.